Janos Demeter

Affiliations: 
Biochemistry Stanford University School of Medicine, Palo Alto, CA, United States 
Google:
"Janos Demeter"

Parents

Sign in to add mentor
Peter Kent Jackson research scientist 2016- Stanford (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Boutelle AM, Mabene AR, Yao D, et al. (2025) Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network. Cell Death and Differentiation
Hammond T, Choi JB, Membreño MW, et al. (2024) THE FAM53C/DYRK1A axis regulates the G1/S transition of the cell cycle. Biorxiv : the Preprint Server For Biology
Vazquez N, Lee C, Valenzuela I, et al. (2024) The human ciliopathy protein RSG1 links the CPLANE complex to transition zone architecture. Biorxiv : the Preprint Server For Biology
Boutelle AM, Mabene AR, Yao D, et al. (2024) Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network. Biorxiv : the Preprint Server For Biology
Wu CT, Lidsky PV, Xiao Y, et al. (2022) SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell
Janas JA, Zhang L, Luu JH, et al. (2022) Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation. Molecular Cell
Yao Y, Du Jiang P, Chao BN, et al. (2022) GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans. The Journal of Experimental Medicine. 219
Raj N, Wang M, Seoane JA, et al. (2022) The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Molecular Cell
Palla AR, Hilgendorf KI, Yang AV, et al. (2022) Primary cilia on muscle stem cells are critical to maintain regenerative capacity and are lost during aging. Nature Communications. 13: 1439
Murray CW, Brady JJ, Han M, et al. (2022) LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer. Nature Communications. 13: 1090
See more...